Fabrication of strontium/calcium containing poly(γ-glutamic acid) - organosiloxane fibrous hybrid materials for osteoporotic bone regeneration

制备含锶/钙的聚(γ-谷氨酸)-有机硅氧烷纤维杂化材料用于骨质疏松性骨再生

阅读:2

Abstract

Recent researches have proved that combination of several therapeutic metal ions, such as silicate (Si), calcium (Ca), strontium (Sr) and so on, with biomaterials may have promising effects for stimulating bone regeneration. In the present study, the Sr/Ca containing silicate hybrid materials (Sr/Ca-γ-PGA-silica) with a mimetic native extracellular matrix (ECM) structure have been developed by electrospinning. With the aim to promote the solubility of γ-PGA in aqueous-based solution and introduce Sr/Ca elements into the prepared hybrid materials, SrCO(3) and CaCO(3) were employed due to their nontoxicity and no by-products during chemical reaction between γ-PGA and SrCO(3)/CaCO(3). Results of SEM, EDX and elemental mapping images showed that Sr and Ca have been successfully incorporated into the prepared fibrous hybrid materials with homogeneous dispersion. Results of ICP-AES revealed that there was continuous Si, Sr and Ca ion release behavior of Sr/Ca-γ-PGA-silica hybrid materials in Tris-HCl buffer solution and the Si ions release rate can be tailored by adjusting the molar ratio of Sr to Ca. Immersion of Sr/Ca-γ-PGA-silica hybrid materials in a simulated body fluid (SBF) resulted in the formation of an apatite-like surface layer within 3 days, indicating their excellent bioactivity. In addition, the prepared Sr/Ca-γ-PGA-silica hybrid materials supported the proliferation and alkaline phosphatase (ALP) activity of osteoblast in vitro, showing their good biocompatibility. Altogether, the results indicated that the prepared Sr/Ca-γ-PGA-silica hybrid materials with an adjusted ionic release behavior have great potential for providing an excellent ECM for osteoporotic bone regeneration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。